Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Mol Cell. 2019 Aug 8;75(3):620-630.e9. doi: 10.1016/j.molcel.2019.05.030. Epub 2019 Jul 3.
mRNA modifications play important roles in regulating gene expression. One of the most abundant mRNA modifications is N6,2-O-dimethyladenosine (m6Am). Here, we demonstrate that m6Am is an evolutionarily conserved mRNA modification mediated by the Phosphorylated CTD Interacting Factor 1 (PCIF1), which catalyzes m6A methylation on 2-O-methylated adenine located at the 5' ends of mRNAs. Furthermore, PCIF1 catalyzes only 5' m6Am methylation of capped mRNAs but not internal m6A methylation in vitro and in vivo. To study the biological role of m6Am, we developed a robust methodology (m6Am-Exo-Seq) to map its transcriptome-wide distribution, which revealed no global crosstalk between m6Am and m6A under assayed conditions, suggesting that m6Am is functionally distinct from m6A. Importantly, we find that m6Am does not alter mRNA transcription or stability but negatively impacts cap-dependent translation of methylated mRNAs. Together, we identify the only human mRNA m6Am methyltransferase and demonstrate a mechanism of gene expression regulation through PCIF1-mediated m6Am mRNA methylation.
mRNA 修饰在调节基因表达中发挥重要作用。最丰富的 mRNA 修饰之一是 N6,2-O-二甲基腺苷(m6Am)。在这里,我们证明 m6Am 是一种受磷酸化 CTD 相互作用因子 1(PCIF1)介导的进化上保守的 mRNA 修饰,该因子催化位于 mRNA 5' 端的 2-O-甲基腺苷上的 m6A 甲基化。此外,PCIF1 在体外和体内仅催化加帽 mRNA 的 5' m6Am 甲基化,而不催化内部 m6A 甲基化。为了研究 m6Am 的生物学作用,我们开发了一种强大的方法(m6Am-Exo-Seq)来绘制其转录组范围的分布,结果表明在检测条件下 m6Am 和 m6A 之间没有全局相互作用,表明 m6Am 在功能上不同于 m6A。重要的是,我们发现 m6Am 不会改变 mRNA 的转录或稳定性,但会对甲基化 mRNA 的帽依赖性翻译产生负面影响。总之,我们确定了唯一的人类 mRNA m6Am 甲基转移酶,并通过 PCIF1 介导的 m6Am mRNA 甲基化证明了一种基因表达调控机制。